Pioneering cord blood transplantation in relapsed/refractory HIV-related lymphoma: a case study with concurrent intramuscular antiretroviral therapy
A 44-year-old HIV-positive man diagnosed with diffuse large B-cell lymphoma in 2021 achieved complete remission with six cycles of R-CHOP therapy but had a relapse in November 2022.ESHAP therapy failed to induce Thumb remission, leading to complete remission with four cycles of Pola-BR therapy.Post-failure of autologous stem cell harvest, Deep Frye